Biochemical Alterations of Stored Erythrocyte Membranes
NCT ID: NCT02639780
Last Updated: 2022-01-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
36 participants
OBSERVATIONAL
2015-12-31
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microvesicle Production After Acute Trauma and Its Clinical Impact on Venothromboembolism
NCT01264458
NOAC Plasma Concentration and Blood Coagulation in Healthy Volunteers
NCT03666650
Safety and Feasibility of Argatroban As Anticoagulant in Adults with ECMO
NCT05226442
Reversal of the Antithrombotic Action of New Oral Anticoagulants
NCT01478282
Comparative Evaluation of the Performance of Different Thromboplastin Reagents on Prothrombin Time and Factorial Assays in Situations of Isolated Extrinsic Pathway Factor Deficiency or Liver Damage.
NCT06705829
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy young female
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
healthy young male
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
healthy older female
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
healthy older male
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
obese older female
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
obese older male
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
protein expression pattern of packed red blood cells
the proteome of packed red blood cells will be assessed at predefined time points
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* group 2: healthy male volunteers 18-35 y.o.
* group 3: healthy female volunteers 36-60 y.o.
* group 4: healthy male volunteers 36-60 y.o.
* group 5: female volunteers 36-60 y.o., BMI 26-45
* group 6: male volunteers 36-60 y.o., BMI 26-45
Exclusion Criteria
* age above 60 years
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Scientific Fund of the Mayor of Vienna
OTHER
European Society of Anaesthesiology
OTHER
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David M Baron, MD
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1043/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.